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SUMMARY. A dose-response relationship may be best modeled by a trino-
mial response: for example with the three categories "no reaction", "efficacy", 
and "adverse outcome". Applications of such a model in both clinical tri-
als and toxicology will be described. Optimal designs will be found using 
Bayesian criteria. In addition a new concept is defined, "limiting optimality", 
where a sequence of designs is said to be optimal in an asymptotic sense for 
a sequence of prior distributions. General algebraic forms of limiting optimal 
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designs for a continuation-ratio model will be given. These limiting optimal 
designs will be shown to be very efficient and practically useful. Conditions 
will also be found, by empirical investigation, under which a simplifying as-
sumption of constant slopes is reasonable in this model. 
Key words: Continuation ratio; Multinomial responses; Optimal designs; 
Phase I/II Clinical trials. 
1 Introduction 
There are many important design problems where the dose response is a 
multinomial distribution: Zocchi and Atkinson (1999) give a toxicology ex-
ample with a trinomial response to dose (survival after emergence/death after 
emergence/death before emergence); Thall and Russell (1998) present a new 
strategy for phase I/II trials where the response to dose is trinomial (no re-
action/efficacy /adverse outcome); Heise and Myers (1996) discuss a clinical 
trial with a bivariate binary response to dose, efficacy (yes/no) and toxicity 
(yes/no). This last example can be though of as a multinomial response 
with 4 cells: the two cells corresponding to the occurrence of toxicity can be 
collapsed together to give a trinomial response. Other examples are given in 
Glonek and McCullagh (1995), Glonek (1996), and Zhu, Krewski and Ross 
(1994). 
In this paper an ordinal trinomial response is considered and a continuation-
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ratio model is adopted (Agresti, 1990, Chapter 9). The response when ni ex-
perimental units are given a dose xi is trinomial, (Yli, Y2i, Y3i), Yti +Y2i +Y3i = 
ni. The corresponding cell probabilities are (p1(0,xi),p2 (0,xi),p3 (0,xi)), 
where 0 is the parameters of the model. For any x and 0, p1 ( 0, x) + p2 ( 0, x) + 
p3 (0, x) = 1. The continuation-ratio model is 
log[p3(0, xi)/(1 - p3(0, xi))] - a1 + b1x 
log[p2(0, x)/P1 (0, x)] - a2 + b2x. 
(1) 
(2) 
For a fixed sample size n, the design problem is to choose the number of dose 
levels, k, the dose levels, x1, .•. , xk, and the number of experimental units, 
ni, at each Xi, such that Eni = n. 
To illustrate the model, a plot of the probabilities (p1 ( 0, x), p2 ( 0, x), p3 ( 0, x)) 
for a1 = 0, a2 = 2, b1 = b2 = 1 is shown in Figure l. Suppose that x is the 
dose level, p1(0, x) is the probability of no reaction, p2 (0, x) is the proba-
bility of efficacy, and p3(0, x) is the probability of an adverse outcome. As 
the dose level increases, p1 ( 0, x) is increasing and p3 ( 0, x) is decreasing. The 
probability of efficacy, p2 (0, x), increases to a maximum and then decreases: 
a very low dose is likely to do nothing and an extremely high dose is likely 
to cause an adverse outcome or death. This is similar to Scenario 2 of Thall 
and Russell (1998). 
An experimental design will be regarded as a probability measure on the 
dose domain X. The design r, puts weight mi at dose xi for i = 1, 2, ... , k, 
L 
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Figure 1: Probability plot: probability vs. dose for a1 
b1 = b2 = l. 
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O,a2 - 2, and 
mi = ndn the fraction of observations to be taken at that dose. The val-
ues mi, i = 1, ... , k, are non-negative and sum to one over i, but are not 
otherwise constrained. A design can therefore be thought of as a probability 
measure, 'f/ on X. A design putting weight mi at dose xi for i = 1, 2, ... , k 
will be written as (m1, m2 , ... , mk) at (x1 , x2, ... , xk). For a given sample size 
n the values nm/scan be rounded to integers in a systematic way to run an 
experiment (Pukelsheim, 1993, Chapter 12). 
Designs are derived for the model described by (1) and (2) which optimize 
several criteria based on the Fisher information matrix (see Silvey, 1980). 
The inverse of the Fisher information matrix gives the asymptotic variance 
covariance matrix for the maximum likelihood estimate (MLE). The infor-
mation matrix depends on both the design, denoted by 'f/, and the parameter 
values, denoted by 0. Expressions for the information matrix, M ( 0, 1J), of 
the constant-slope model, where b1 = b2 , and also of the more general model 
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where the slopes b1 and b2 are not necessarily equal, are in Appendix A. 
Local D-optimality chooses the design which maximizes the determinant 
of the information matrix at a single value of the parameters; that is, it is 
the 'f/ that maximizes <P(rJ) = logdetM(0, rJ). This criterion should make the 
asymptotic variances of the MLE's small, in a general sense, if the specified 
value of 0 is close to the true value of 0. The same criterion averaged over 
a distribution on the parameters, 1r, gives "Bayesian" D-optimality: <P(rJ) = 
E1rlogdetM(0, rJ). This criterion is typically a more robust criterion than 
local D-optimality and is better over a range of values for 0. An alternative 
criterion, c-optimality, will also be used, which minimizes the asymptotic 
variance of a specific quantity of interest. Suppose that the quantity of 
interest is a single function of the parameters, denoted g(0), and denote 
the gradient vector of g(0) as c(0) = 8~~) (as used in the delta method for 
calculating an asymptotic variance, see eg. Agresti, 1990, Chapter 12). Then 
the c-optimality criterion is <P(rJ) = -E1rc(0)T /1,11(0, rJt 1c(0). The expectation 
is either over a prior distribution 1r (Bayesian c-optimality) or over a point 
mass distribution (local c-optimality). The specific example examined here is 
where g(0) = Xmax, the dose at which the probability of efficacy is maximized. 
Putting a distribution on the unknown parameters to reflect the uncertainty 
prior to experimentation is very appealing from a design perspective: see 
Verdinelli {1992) and Chaloner and Verdinelli (1995) for a review of Bayesian 
approaches to design. Applications and examples of locally optimal designs 
are given in Kitsos, Titterington, and Torsney (1988), Ford, Torsney, and 
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Wu (1992), and Wu (1988). For a general discussion of the design problem 
for dose response see Wong and Lachenbruch (1996). 
1.1 Examples 
Example 1: Toxicological Example - The following example is reported 
in Zocchi and Atkinson, together with a data set. In the data set n = 3,500 
house fly pupae (Musca domestica L., 1758) are assigned to be exposed to a 
level, Xi, of gamma radiation, with ni = 500 pupae at each level i = 1, ... , 7. 
After a period of time the number of flies that emerge from the pupae and 
survive is denoted y1, the number that died after emergence is denoted y2 , and 
the number that died before emergence is denoted y3• (Zocchi and Atkinson 
used different notation and a different model but the model, (1) and (2), is 
.similar.) The design problem is to choose the number of levels and doses of 
gamma radiation, and to choose the number of pupae to assign each dose. 
In this example sequential design is not an option because a period of 
time elapses between the application of the dose, xi, and the response, Yi. 
Batch sequential design might be an option (as in Sitter and Wu, 1999) but 
is not explicitly considered here. Ethical considerations do not enter into this 
design example as they do in Example 2. 
Example 2: Phase 1/11 Clinical Trial - Thall and Russell (1998) pro-
pose a practical new strategy for phase I/II trial design and conduct. They 
describe several such phase I/II trials. One is a cancer clinical trial where 
patients with advanced hematologic malignancies or lymphoma are assigned 
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to a combination drug dose x. Two response variables are of interest: severe 
toxicity (yes/no) and graft-versus-host disease (none, moderate, severe). The 
response is therefore a six cell multinomial. As the adverse outcome is very 
severe, and includes death, Thall and Russell collapse into 3 cells of inter-
est (no reaction/efficacy /adverse outcome). Because it is important not to 
expose patients to undue toxicity, important dose limiting constraints en-
ter into the design. Thall and Russell use a sequential strategy, for finding 
a dose satisfying both safety and efficacy requirements, based on Bayesian 
methods. As the designs derived in this paper are non-sequential, and do not 
take ethical constraints into account, they are not immediately applicable to 
this particular class of clinical trials, but they do provide a useful benchmark 
with which to compare, and possibly improve upon, the designs of Thall and 
Russell. Additional discussion of ethical constraints is given in Thall, Estey, 
and Sung {1999) together with a description of an ongoing trial for donor 
lymphocyte infusion which uses their strategy. 
1.2 Summary 
A new concept of "limiting optimality" is introduced in Section 2 for a se-
quence of designs which are approximately optimal. This concept enables 
the construction of designs with closed form expressions. Closed form de-
signs provide starting points for numerical algorithms and they also provide 
benchmarks against which sequential, or other strategies can be evaluated. 
They are also shown to be remarkably efficient for the models studied here. 
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Section 3 gives designs for the constant-slope model (b1 = b2 ), and also for 
the model where the slopes are not necessarily equal. Designs for Example 2 
are given in Section 4. Finally, Thall and Russell (1998) use a three parameter 
model making an assumption that the slopes are equal: this assumption is 
investigated empirically in Section 5. 
2 Limiting Optimal Designs 
Designs are thought of as probability measures and the criteria to be used are 
all concave functions over the set of probability measures, 1-l, on the design 
region X (see Silvey, 1980). The General Equivalence Theorem (as given in 
·whittle, 1973, and extended in Chaloner and Larntz, 1989) can be used and 
is given in Appendix 8. The optimization is multidimensional: the number 
and values of support points and the weight at each support point must be 
chosen. The theorem means that after a candidate design has been found, 
by numerical or other methods, its global optimality can be easily verified 
by merely checking that a simple function of the variable x is non-positive. 
Define a one point design, putting all mass at x E X as 'T/x· Then a design 'T/o 
at which the criterion, </>, is differentiable is optimal for a prior distribution 1r, 
if, and only if, the directional derivative F</J('T/o, rJx, 1r) at 170 in the direction of 
all one-point designs, 'T/x for x in X, is non-positive. (If the distribution 1r is a 
one-point probability measure then the criterion is that of local optimality.) 
The directional derivative at 170 in the direction 17 for a prior distribution 1r 
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is: 
For D-optimality and c-optimality, F¢('f/o, 'f/, 1r) is calculated easily: formulas 
are given in Appendix B. 
The following defines a new concept of a sequence of limiting optimal 
designs. 
Definition 1. For a concave criterion </> on a set of design measures 1l, 
a sequence of designs, { 'f/i, i is an integer}, is called a sequence of limiting 
optimal designs </> for a sequence of prior distributions, { 7l"i, i is an integer}, 
if 
sup F<t,('f/i, 'f/, 7ri) = di > 0 
TJE1l 
and di -+ 0 as i -+ oo. Each design of this sequence, say 'f/i, is called a 
limiting optimal design of 7l"i. 
These limiting optimal designs are not optimal but tend to be optimal as 
the index i goes to infinity. 
Lemma 2.1. Consider a concave criterion </>, a sequence of priors, 1l"i, and 
the corresponding limiting optimal designs, T/i· Let r,; be the Bayesian optimal 
design for prior 1l"i· If the limit and integral in F<t,('T/i, 1Ji, 1l"i) are reversible, 
i.e. F<t,(rJi, 11;, 7ri) = E1rJimi-+o+ ¼{ </>(0, (1 - E)rJi + ErJ;) - </>(0, 17i) }], then, 
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¢,(1ri, rJ;) - ¢,(1ri, 'f/i), the difference in the value of the criterion at design T/i, 
and at design 'f/i, goes down to zero as i --+ oo. 
Proof See Appendix C. D 
If a criterion ¢, is concave and differentiable at 'f/i for each integer i, then 
{ T/i, i is an integer} is a sequence of limiting optimal designs for a concave 
criterion ¢, for a sequence of prior distributions, { 1ri, i is an integer}, if 
sup Fq,(rJi, 'f/x, 1ri) = di > 0 
xEX 
and di --+ 0 as i --+ oo. Because these limiting designs are not exactly 
optimal, it is important to examine their efficiencies. The following definition 
of efficiency is used. 
Definition 2. The efficiency of a design rJ is defined to be the sample size 
required for an experiment using the optimal design to reach the same value 
of the criterion as an experiment using design rJ with sample size one. 
3 Optimal Designs 
Constant slopes (b1 = b2 ) will be initially assumed. The three cells of the 
trinomial response are denoted as no reaction/ efficacy/ adverse outcome. Let 
u = a2 - a1 . Figure 2 indicates that the value of u is a measure of how 
good the drug/therapy is. Larger values of u give wider ranges of dose level 
with low probability of adverse outcome in the range of efficacy. A negative 
. 
... 
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Figure 2: From the left to the right: probability plot, probability vs. dose, 
for a1 = 0, b1 = 1, and u = 0, 5, and 10, respectively. 
u value indicates a bad drug since the probability of efficacy is very low at 
most dose levels. Negative u values will, therefore, be only briefly discussed. 
For convenience 0 will be rewritten as ( u, a1, b1) but the information matrix 
with 0 = (a1, b1 , a2 ) in Appendix A is used to find the optimal designs. 
D-optimal Designs 
Define two sets of parameters: 00 =(u, 0, 1), and 0 = (u, a1, b1). Also define 
design 'f/o = (m1, m2, ... , mk) at (x1, x2, ... , xk) and design 'f/ = (mi, m2, ... , mk) 
at (x1bia1 , x2biai, ... , x,.biai ). Then it is easily shown algebraically that: det(.l\1(0, 'f/)) = 
b12 det(M(0o, "lo)). Therefore 
Lemma 3.1. If "lo= (mi,m2, ... ,mZ) at (xi,x2, ... ,xZ) is locally D-optimal 
I 0 ( 0 1) th * ( * * *) t (xj-a1 x;-a1 x;-a1) . l Jor O = u, , en 'f/ = m 1 , m 2 , ••• , mk a bi , bi , ••• , bi is a so 
locally D-optimal for 0 = ( u, a1, bi). 
Proof. As det(.M(0, 'f/)) = b12 det(M(00 , "lo)) and the transformation r,0 ....+ 'f/ 
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is one-to-one and onto, maximizing logdet(M(0, 77)) is the same as maximiz-
ing logdet{M{00 , 770 )) over all possible designs 17 and 770 • D 
Without loss of generality, therefore, a1 = 0, b1 = 1 will be assumed for 
deriving locally D-optimal designs. 
Locally D-optimal designs are first found numerically. The number of 
support points of the locally D-optimal design depends on the value of u = 
a2 - a1 alone. If u is positive then the locally D-optimal design has either two 
or three or four support points. Figure 3 illustrates that for a small u value, 
u = 0 say, the locally D-optimal design is 2-point; for a slightly larger u 
value, u = 5, it is 3-point; and for a large u value, u = 10, it is 4-point. The 
numerical optimization guarantees a local optimum, and global optimality 
can be checked using the General Equivalence Theorem in Appendix B which 
just requires that its directional derivative is everywhere non-positive. Figure 
4 shows the directional derivatives, and they are nonpositive and equal to 
zero at the design points. If u is negative, the locally D-optimal designs are 
typically 2-point designs. 
The probability plot for u = 10 in Figure 2 looks like two separate, single 
logistic regressions in separate regions of the dose range. One logistic regres-
sion is on the left and is for no reaction/efficacy, with adverse outcome having 
a negligible probability, and the other is on the right for efficacy/ adverse out-
come, with the probability of no reaction being negligible. >From results for 
a single logistic regression {White, 1975, for example), a 4-point design with 
equal weights, two points for each logistic regression, seems therefore a good 
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initial guess. The following result shows that such a strategy is, in fact, 
limiting D-optimal. 
Theorem 3.2. Suppose a1 = 0 and b1 = l. As u goes to oo, the design 
'T/* putting equal weight at x = {1.223, -1.223, -u + 1.223, -u - 1.223} is 
limiting locally D-optimal. 
Proof. See Fan (1999, Chapter 5). The proof shows that let u be the index 
i and then di, as in Definition 1, is such that di ---t 0 as i ---t oo. D 
The probability of the responses at the four design points are shown in 
Table 1. In addition, the limits as u ---t oo, of these probabilities are given in 
Table 2. 
I x (dose) no reaction efficacy I adverse outcome I 
1.223 0.227 4 1..i..,_,uil.223 
0 2274 eu-t-i ....... 
• l+eu+l.223 0.7726 
-1.223 0. 77261-1-eu~l.223 0 7726 eu 1.m 
· 1 +eu-1.223 0.2274 
-u + 1.223 0.227 4 l+e-f+I.223 0. 7726 l+e-!+1.223 e-U-t-.l."'"'" 1 +e-u+l.223 
-u - 1.223 0. 7726 l+e-!-1.223 0.2274 l+e-f-1.:!23 e " , ........ l+e-u-1.223 
Table 1: Probabilities at design points of the limiting design. 
x (dose) I no reaction I efficacy I adverse outcome I 
1.223 0 0.2274 0.7726 
-1.223 0 0.7726 0.2274 
-u + 1.223 0.2274 0.7726 0 
-u - 1.223 0.7726 0.2274 0 
Table 2: The limits of probabilities at design points of the limiting design, 
as u goes to oo. 
a, 
0 
•2 
·12 
-12 
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woighl 0.5249 et -1.54 
weighl0.4751 DI0.73 
0.5249 
•I 
weight 0.3061111-5.63 
weigh! 0.3924 DI •2.71 
weight 0.3014 et 0.6088 
-10 
weigh! 0.2507 111 ·11.2 
weight 0.2509 DI -8.75 
weight 0.2488 DI •1 ,24 
weight 0.2497 111 1.193 
0.2507 0.2509 
•10 
-8 
•B 
u=O 
0.4751 
xi 
u=S 
0.3924 
0.3061 0.3014 
·2 
xi 
U=10 
0.2488 0.2497 
-2 0 
xi 
Figure 3: Locally D-optimal designs for u = 0, 5, and 10. 
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Figure 4: Directional derivative plots of D-optimal designs for a1 = 0, b1 = 1, 
and several u values. 
Lemma 2.1 guarantees that for large u values these limiting designs are 
efficient. Figure 5 shows that the efficiencies (as defined in Definition 2) for 
small u values are suprizingly efficient: efficiencies are all higher than 97%. 
As u goes to -oo, p2(0, x) tends to 0, so this model becomes that of 
a single logistic regression. A candidate limiting locally D-optimal design 
therefore puts weight 1/2 at each of a1 ± 1.543b1, the well documented locally 
optimal design for a single logistic regression. The efficiency of this design 
for u = -20 is 95.7%. 
A general form of Bayesian D-optimal designs, for arbitrary prior distri-
butions, is intractable in closed form but designs can be found numerically (as 
in Section 4). For any prior distribution putting uncertainty only on u (for 
fixed a 1 and b1), a general property of Bayesian D-optimal designs is given 
here. In addition, for a simple prior distribution, a general form of (limiting) 
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Figure 5: Efficiency plot of limiting locally D-optimal design: efficiency vs u. 
Bayesian D-optimal designs is found and is shown to be very efficient. 
Let the prior distribution 1r put weight 'Tri at 0 = (ui, a1, bi) and let 
the prior distribution 1r0 put weight 'Tri at 0 = (ui, 0, 1). It can be shown 
by straightforward algebra that if 11~ = (mi,mi, ... ,mk) at (xi,xi, ... ,xn is 
the Bayesian D-optimal design for prior 1r0 then 17* = (mi, m2, ... , mk) at 
( xj-ai x;-ai xi-ai). th B . D . l d . £ . bi , bi , ••• , bi 1s e ayesian -optima es1gn or pnor 1r. 
Without loss of generality, therefore, again assume a1 = 0, b1 = 1. Con-
sider a simple prior distribution 1r with two equally weighted support points: 
(0, 0, 1) and (u, 0, 1). The following result was suggested by numerical explo-
ration and was then proved. 
Theorem 3.3. Let the prior 1r be as above. Then the design 17 putting weight 
0.16667, 0.44825, 0.38508 at -u, -1.47128, 1.14271, respectively, is a limiting 
Bayesian D-optimal design for the prior distribution 1r as u---+ oo. 
Proof. See Fan (1999, Chapter 5) for a proof similar to that of Theorem 
Designs for a Trinomial Response 17 
I'-
~ 
~ 
0 
M 
M 
~ 
0 
In 
I'-
0 
0 2 4 6 8 10 
Figure 6: Efficiency plot of limiting Bayesian D-optimal design: efficiency vs. 
u 
3.2. D 
The limiting designs are again very efficient, as is shown in Figure 6: all 
efficiencies, as defined in Definition 2, are higher than 97.8%. 
For unequally weighted prior distributions, Fan (1999, Chapter 5) gives 
some examples and conjectures for the limiting Bayesian optimal design. 
c-optimal Designs 
Suppose the goal of the experiment is finding the dose, Xmax, which maximizes 
p2(0, x), the probability of efficacy. The value Xmax = - 012t;2 is a function 
of 0: Xmax = g(0). Let c(0) be the gradient vector of g(0). The asymptotic 
variance of the MLE of Xmax, for a design rJ, is c(0f M(0, 1J)-1c(0). Then 
c-optimality minimizes this asymptotic variance. 
Similarly to Lemma 3.1, if 11~ = (mi, m2, ... , mk) at (xi, x2, ... , xn is locally 
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Figure 7: Efficiency plot of limiting c-optimal designs: efficiency vs. u. 
· 1£ 0 -( 0 1) h * _ ( * * *) t (xj-a1 x;-a1 x;-a1) c-optima or O - u, , t en 'f/ - m 1 , m2 , ••• , mk a bi , bi , ... , bi 
is also locally c-optimal for 0 = (u, a 1, bi). Without loss of generality, there-
fore, only c-optimal designs for a1 = 0, b1 = 1 will be explored here. 
Theorem 3.4. Suppose a1 = 0, b1 = 1. As u = a2 - a1 goes to oo, the 
design r, putting 1 /2 weight at each of x = 0 and x = -u is a limiting locally 
c-optimal design for Xmax. 
Proof. See Fan (1999, Chapter 5). D 
For u between 2.5 and 4 these limiting designs are over 75% efficient, and for 
u greater than 4 over 95% efficient, as shown in Figure 7. 
For a very small value of u, 0.1 say, numerical problems sometimes arise 
finding locally c-optimal designs. The limiting designs above can serve as 
starting designs for optimization to avoid such problems. When u is O the 
c-optimal design becomes a singular one-point design. 
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Theorem 3.5. The c-optimal design of a1 - 0, b1 - 1, and u 
one-point design putting mass 1 at x = 0. 
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0 is a 
Proof. See Fan (1999, Chapter 5) for the proof which uses an equivalence 
theorem for singular optimal designs, as given, for example, in Silvey (1980, 
Chapter 3). D 
Singular designs are of extremely limited direct practical use as the param-
eters are not all estimable. They are however useful in sequential strategies 
and as benchmarks. 
Different Slopes 
For a more general model where b1 is not necessarily equal to b2 , limiting 
locally D-optimal and Bayesian D-optimal designs are given in Fan (1999, 
Chapter 6). They are, however, not as efficient as in the constant-slope 
model. In some cases, the efficiency can be as little as 60%, even for quite 
large values of u, u = 20 say. The criterion for c-optimality for estimating 
Xmax is not straightforward to implement in this more general model as there 
is no closed form expression for Xmax. 
4 Optimal Designs for Example 2 
Thall and Russell (1998) provided a prior distribution determined by clin-
icians and statisticians together. A discrete approximation to their prior 
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distribution, which simplifies the numerical optimization, together with our 
slightly different model, is used here for illustration. Only three support 
points for each parameter are used, centered at the values used by Thall and 
Russell: -6, -3.5, -1 for a1 ; -5, -1, 3 for a2 ; 0.04, 0.22, 0.40 for b1• The prior 
distribution has 3 x 3 x 3 = 27 support points and is uniform, with weight 
1 /27 at each point. The Bayesian D-optimal design is found numerically, 
and is an 8-point design, putting weight 0.0173, 0.1143, 0.2049, 0.1736, 0.1904, 
0.1288, 0.06504, and 0.1058 at x = -94, -8.97, -0.185, 6.064, 11.35, 17.54, 28.08, 
and 124, respectively. Its optimality has been verified by its directional 
derivative plot. 
The Bayesian c-optimal design for estimating the dose with the highest 
probability of efficacy, Xmax, is also found numerically. It is also an 8-point 
design, putting weight 0.0290868, 0.128426, 0.152321, 0.276159, 0.103444, 
0.101994, 0.156102, 0.0524675 at X = -86.2186, -8.9973, 2.61665, 9.84083, 
17.5687, 25.9459, 107.829, and 142.552, respectively. Its optimality has also 
been verified by its directional derivative plot. 
5 When Can Constant Slopes be Assumed? 
Thall and Russell (1998) assume constant slopes for their very similar model, 
but they give no evidence justifying this assumption. The robustness of 
constant slopes assumption will be explored here in the following three ways: 
1. examining the efficiency of the optimal design for the constant-slope 
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model when the slopes are actually not equal. 
2. examining the values to which the maximum likelihood estimates of 
the constant-slope model converge, and by how much the fitted prob-
ability curves differ from the true probability curves, when the slopes 
are assumed equal but are not. 
3. examining the performance of the optimal design for the constant-slope 
model for a small sample when the slopes are actually not equal. 
The parameter vector of the different-slope model is denoted as 0 and that 
of the constant-slope model is denoted as 0 = ( u, a1, b1). 
5.1 Efficiency of Optimal Designs 
Let r = bi/b2 and d = a1 - ra2 • From Equation (1) and (2), it can be shown 
that for fixed a2 , b2 , and r, the smaller dis, the better this drug/therapy is 
( the higher the probability of efficacy and the lower the probability of adverse 
outcome). This can also be seen from Figure 8, which shows probability plots 
for a2 = O,b2 = 1, r = 0.8, and d = -5,0. 
Let ij* be the locally D-optimal design for the constant-slope model with 
0 = ( a2 - a1, a 1, b1), and r,* be the locally D-optimal design of the model with 
0 having the same values of a1, a2 , and b1, but b2 not necessarily equal to b1: 
termed the different-slope model. 
Lemma 5.1. For fixed a1 , a2 and r, under D-optimality and the different-
slope model, the efficiency of rj* {compared tor}*, as in Definition 2} does not 
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Figure 8: Probability plots, probability vs. dose, for a2 = 0, b2 = 1, r = 0.8, 
and d = -5 (left); d = 0 (right). 
depend on the value of b2. 
Without loss of generality b2 = 1 is assumed for this subsection. 
The efficiency of rj*, the locally D-optimal design of the constant-slope 
model, under the different-slope model were studied in Fan (1999, Chapter 
7). In this dissertation efficiency plots of efficiency against d were drawn for 
a2 = -1, 0, 1, 2, 5, and r = 0.5, 0.8, 0.9, 1.0, 1.1, 1.2, 2.0. They were all similar 
and the plot for a2 = -1 is shown in Figure 9 for illustration. Overall, for 
this range of parameter values, if 0.9 ::; r ::; 1.1, that is b1 is within 10% of 
b2 , the efficiency is over, or very close to, 90%. 
5.2 Convergence of MLE's 
Huber (1967) showed that if the true distribution does not lie within the 
specified parametric class (b1 = b2 here) then, as the sample size goes to 
COO>O ..- C\! 
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Figure 9: Efficiency plot for a2 = -1: efficiency vs. d. 
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oo, the MLE approaches the value corresponding to the distribution in the 
parametric family closest to the true distribution in terms of the directed 
Kullback divergence. For any design, therefore, these values can be calculated 
numerically. 
Suppose that the constant-slope model is adopted for data analysis and 
the D-optimal (or c-optimal) designs for the constant-slope model are used. 
Lemma 5.2. Let the true parameter vector in the different-slope model, 0, 
be (a1 , b1 , a2 , b2 = bi/r). If the MLE in the constant-slope model, (ai, bi, ai), 
converges to ( ai, bi, a2) for bi = 1, then J or bi = b and the same ai, a2 and r 
values, this MLE converges to (ai, bbi, a2). 
Without loss of generality bi = 1 will be assumed for this subsection. 
Using D-optimal Designs for the Constant-Slope Model 
The true probability curves and the asymptotic fitted probability curves were 
drawn on the same plot for 208 parameter values. The 208 plots drawn cor-
responded to: a2 - a 1 = -5, 0, 5, 10, ai = -1,-0.5, 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 
4, 4.5, 5, bi = 1, and b2 = 0.9, 0.95, 1.05, 1.1. In the plots where b2 is less than 
10% different from b1 , the asymptotic fitted probability curves can barely be 
distinguished from the true probability curves. Figure 10 is an example. 
Using c-optimal Designs for the Constant-Slope Model 
This part will study the performance of c-optimal designs for the constant-
slope model. The error of both estimates and confidence intervals used for 
Designs for a Trinomial Response 25 
a1=·1,b1=1,a2=-1,b2:0.9 a1=·1,b1=1,a2=-1,b2=1.1 
~ 
. 
0 
: 
f I= :;i:i:1 ;: 
.. 
0 
~ 
10 ,IS ·10 -5 10 
Figure 10: Probability plots, probability vs. dose, for a1 = -1, b1 = 1, a2 = 
-1, and b2 = 0.9 (left); b2 = 1.1 (right). The solid curves are made by the true 
values of parameters while the dashing curves are made by the asymptotic 
values of MLE's. 
inferences will be explored. 
Denote the MLE of Xmax in the constant-slope model as Xmax = - ai +b,._a2 • 
2 1 
This MLE, Xmax, will be used to estimate Xmax· The asymptotic limit of Xmax, 
. aj+a; x:nax, 1s - 2b. . Two errors are defined: 1 
error 
- Xmax - Xmax 
asyerror * 
- Xmax - Xmax · 
Also let A.S.E. be the estimated asymptotic standard error of Xmax in the 
constant-slope model ( ai, bi, and a; as parameter estimates), and let A. A. S. E. 
be the limit of A.S.E., which can be obtained by using ai, bi, and a2 as pa-
rameters. Let 0 =(ai, bi,£½), 0* = (ai', bi, a2), and ]\l/(0, rJ) be as defined in 
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Appendix A. Then: 
A.S.E. = /c(0)T M(if, rJ)- 1c(0) 
A.A.S.E. - Jc(0*)T M(0*, TJ)-1c(0*) 
If a1, a2, r are fixed: 
1. asyerror is equal to ( asyerror for b1 = 1) / b1 
2. A.A.S.E. is equal to (A.A.S.E. for b1 = 1)/b1 
26 
Assume also that the sample size, n, is 100. Figure 11 illustrates how asyerror 
changes as b2 changes, for different u and a1 values. The usual approximate 
95% confidence interval (C.I.) of Xmax is Xmax ± l.96A.S.E .. Figure 12 shows 
the asymptotic 95% C.1., x:'nax ± l.96A.A.S.E. for u = -3 and different a 1 
values. 
In Fan's 1999 dissertation many plots for different cases are shown sys-
tematically for 0.9 < b2 < 1.1 (b2 is less than 10% different from b1). In 
all plots the I asyerror I and A. A. S. E. are both small if b2 is less than 10% 
different from b1 . 
5.3 Small Sample Performance 
This section will explore the estimation of Xmax using c-optimal designs ( for 
estimating Xmax) and D-optimal designs, for a sample size of 20. 
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Figure 11: Plots of asyerror vs. b2 • The solid lines are for a1 = -1, the 
dashed lines are for a1 = 2, and the double dashed lines are for a 1 = 5. 
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Figure 12: Plots of asymptotic 95% C.I. for u = -3, and n = 100. The solid 
line is error, the dashing line is the upper limit of the 95% C.I., and the 
double dashing line is the lower limit of the 95% C.I .. 
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The distribution of error, Xmax-Xmax, of incorrectly using optimal designs 
for the constant-slope model with 0 = (u, a1, b1) while a true parameter 
vector, 0, has the identical u, a1, and b1, but b2 is not equal to b1 , does not 
depend on the value of b1. Hence, b1 = 1 is assumed. Since a large value of 
a1 is seldom expected, only a1 = -1, 0, and 2 were explored. If r = bi/b2 
is not close to one, the constant-slope model should not be used, so only 
r = 0.9, 0.95, 1, 1.05, and 1.1 were investigated. Recall that if r is close to 1, 
the value of u = a2 - a 1 indicates how good this drug/therapy is, so several 
u values: -1, 0, 1, and 5 were chosen. To illustrate, boxplots of error were 
drawn. 
There were several extremely outlying points in these boxplots of error. 
Hence "box only" plots are shown here, which only show the boxes, not the 
whiskers. The boxes are bounded by the upper and lower quartiles. Figure 
13 shows results for c-optimal designs, and Figure 14 shows results for D-
optimal designs. It was found that the interquartile range (IQR) was quite 
small and error was, on average, also small, although the tails were long. In 
most cases, the IQR of error of using D-optimal designs was larger than that 
of using c-optimal designs. In the u = -1, a1 = 0, and r = 0.9 case, however, 
the IQR of error of using D-optimal designs was smaller than that of using 
c-optimal designs. 
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Figure 13: "Box only" boxplots of error. In each boxplot, u = 1 and r = 
0.9, 0.95, 1, 1.05, and 1.1 from left to right, using c-optimal designs 
{a) a1 = -1 {b) a1 = 0 {c) a1 = 2 
Figure 14: "Box only" boxplots of error. In each boxplot, u = 1 and r = 
0.9, 0.95, 1, 1.05, and 1.1 from left to right, using D-optimal designs 
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5.4 Summary 
To summarize, if b2 is less than 10% different from b1 and the D-optimal 
designs of the constant-slope model are used then the designs are very effi-
cient and also, asymptotically, the fitted probability curves are very close to 
the true probability curves. In addition, when b2 is less than 10% different 
from b1, c-optimal designs for the constant-slope model provide a reasonable 
estimate of Xmax, even for a sample size of 20. 
The results in this section have generally confirmed Thall's and Russell's 
{1998) assumption that the constant-slope model performs reasonably well if 
the different-slope model is true and the slopes are close. Moreover, a useful 
guideline for how close is "close" has been found: if b2 is within 10% of b1, this 
is close enough. In addition, for a small sample, n = 20, the performances of 
c-optimal designs were good. 
6 Conclusions 
This paper has presented designs for a trinomial response model. Limiting 
optimal designs, under the constant slopes assumption, have been introduced 
and shown to be very efficient. The concept of a sequence of limiting optimal 
designs is very general and can potentially be applied to other models. 
Designs for a Trinomial Response 31 
Appendix A: Information Matrices 
Based on the trinomial distribution of a single outcome at a dose level x the 
Fisher information matrix is: 
1. for the constant-slope model (b1 = b2): 
1 x 0 
1(0, x) - p3(0, x)(p1 (0, x) + P2(0, x)) x x2 O + 
P1 (0, x)p2(0, x) 
Pt (0, x) + P2(0, x) 
2. for the different-slope model (b1 -1- b2): 
ea2+b2x 
-
0 0 0 
0 x2 X 
0 x 1 
1 
X 
1(0,x) (1 + ea2+b2x)2(1 + ea1+b1x) 0 
0 
0 0 0 0 
ea1+b1x 0 0 0 0 
(1 + ea1+b1x)2 0 0 1 X 
0 0 X x2 
0 0 0 
X 0 0 
x2 0 0 
+ 
0 0 0 
0 0 0 
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For a design rJ putting mass mi at Xi, i = 1, 2, ... , k, and I: mi = 1 the Fisher 
information matrix is M(0, rJ) = I:i 17J(0, xi)-
Appendix B: General Equivalence Theorem 
Theorem. Define 1-l to be the set of probability measures on X and define 1Jx 
to be the probability measure putting mass one at x E X. Suppose a criterion 
</> is concave on 1-l and differentiable at 17* in 1l. The fallowing are equivalent 
1. </>( rJ) is maximized for rJ E 1l at rJ*. 
For D-optimality and two designs, 170 and rJ, and 0 a vector of p unknown 
parameters: (1r is a prior distribution of 8.) 
Fq,(rJo, rJ, 1r) = E1r[Trace{M(rJ, 0)M- 1(rJo, 0)}] - p. 
Similarly for c-optimality: 
For rJ = 1Jx these derivatives are simple functions of x. 
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Appendix C: Proof of Lemma 2.1 
Proof. By concavity of </J, the following is easily shown, see also Silvey (1980, 
page 18): 
Therefore, 
E1r i [ lim ! { </J ( 0, ( 1 - E) 'f/i + er1;) - <P ( 0, 1Ji)}] f~o+ E 
> E1ri[ lim !{(1 - t:)</>(0, rJi) + t:</>(0, 17;) - </)(0, rJi)}] 
E~O+ € 
- E1rJ</>(0, rJ;) - q,(0, rJi)] 
- E1ri</J(0, 17;) - E1ri</>(0, rJi) 
- </J(1ri, rJ;) - </J(1ri, 1Ji)-
< sup F<I>( 17i, 17, 1ri) 
,, 
- di. 
Since di --+ 0 as i --+ oo, </>( 1ri, 17;) - </>( 'Tri, 17i) goes down to zero as i --+ oo. D 
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